Abstract
Objective: Responsiveness to clopidogrel is characterized by large variablity in platelet inhibition among patients. (1) Enhanced response to clopidogrel correlates with higher risk for bleeding. (2) We sought to evaluate correlation of platelet count and mean platelet volume (MPV) with enhanced clopidogrel response in patients with acute coronary syndrome undergoing PCI. Methods: Two hundred and forty six consecutive patients with acute coronary syndromes (ACS) were included in the study. Patients with thrombocytopenia and those who received glycoprotein IIbIIIa antagonists during and after PCI were excluded (86 patients).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
